Back to search
Pediatric Pulmonary Hypertension
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pediatric Pulmonary Hypertension trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pediatric Pulmonary Hypertension trials you may qualify forChildren with pulmonary hypertension (PH) engage in less physical activity than their peers. This is a concern since adult data support exercise as a non-pharma…
The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children…
Pediatric pulmonary hypertension (PH) shares similarities with PH in adulthood, but specific differences still require unique approaches. Despite major advances…
Children and adults with pulmonary arterial hypertension (PAH) have severely reduced daily activity compared to healthy populations. In adults, investigators re…
Patients are being asked to be in this research study because medical researchers hope that by gathering information about a large number of children with pulmo…
This is a multi-center, perspective, and exploratory study aimed at evaluating the 3-years clinical outcome of Potts-shunt procedure for pediatric patients with…
The purpose of this study to confirm the selexipag starting dose(s), selected based on pharmacokinetic (PK) extrapolation from adults, that leads to similar exp…
The purpose of this study is to evaluate the effect of macitentan on hemodynamic measures at Week 24 in pediatric populations.
To investigate if the inflammatory protein, high mobility group box 1 (HMGB1), along with other inflammatory mediators, is elevated in pediatric patients with c…